Balance Sheet
Cash Flow Statement
Amortization of Deferred ChargesAmortizatization of IntangiblesCapital ExpendituresCash from Financing ActivitiesCash from Investing ActivitiesCash from OperationsChange in Account PayablesChange in Accured ExpensesChange in CashChange in ReceivablesDepreciation & Amortization (CF)Exchange Rate EffectFree Cash FlowGains from Investment SecuritiesNet Cash FlowNet IncomeOther Working Capital ChangesShare-based Compensation
Daily Values
Growth Metrics
Income Statement
Others
Ratios

Gossamer Bio (GOSS) Capital Expenditures: 2022-2025

Historic Capital Expenditures for Gossamer Bio (GOSS) over the last 1 years, with Jun 2025 value amounting to $53,000.

  • Gossamer Bio's Capital Expenditures was N/A to $53,000 in Q2 2025 from the same period last year, while for Jun 2025 it was $212,000, marking a year-over-year change of. This contributed to the annual value of $410,000 for FY2022, which is 73.48% down from last year.
  • Gossamer Bio's Capital Expenditures amounted to $53,000 in Q2 2025, which was up 103.85% from $26,000 recorded in Q1 2025.
  • In the past 5 years, Gossamer Bio's Capital Expenditures registered a high of $157,000 during Q1 2022, and its lowest value of $26,000 during Q1 2025.
  • Moreover, its 1-year median value for Capital Expenditures was $39,500 (2025), whereas its average is $39,500.